论文部分内容阅读
目的 :探究铝碳酸镁联合奥美拉唑治疗活动期胃溃疡的临床效果。方法 :选择2015年6月-2016年7月我院收治的28例胃溃疡活动期患者为实验人群,按照单双号次序,分为两组,每组28例。病患办理好住院手续后,实施基础治疗,观察组患者在使用奥美拉唑治疗的同时,继续服用铝碳酸镁咀嚼片。对比两组的治疗效果。结果 :观察组溃疡面愈合时间显著较短,对照组患者治疗有效率为71.43%,观察组治疗有效率为92.86%。P<0.05。对照组患者恶心2例,呕吐1例。不良反应率为21.43%。观察组恶心1例。不良反应率为7.14%。经治疗后,患者好转,未对后续治疗造成影响。两组患者相关数据存在统计学差异,P<0.05。结论 :使用铝碳酸镁联合奥美拉唑进行治疗活动期胃溃疡,安全性强,风险小,临床效果好,值得进一步推广。
Objective: To investigate the clinical effect of magnesium aluminum carbonate combined with omeprazole in the treatment of active gastric ulcer. Methods: From June 2015 to July 2016, 28 active gastric ulcer patients treated in our hospital were selected as the experimental group. According to the order of single and double numbers, the patients were divided into two groups (n = 28 in each group). Patients with good hospitalization, the implementation of basic treatment, observation group patients with the use of omeprazole treatment, while continuing to take aluminum magnesium carbonate chewable tablets. Compare the treatment effect of two groups. Results: The ulcer healing time was significantly shorter in the observation group. The effective rate was 71.43% in the control group and 92.86% in the observation group. P <0.05. In the control group, nausea occurred in 2 cases and vomiting in 1 case. Adverse reaction rate was 21.43%. Observation group nausea in 1 case. Adverse reaction rate was 7.14%. After treatment, the patient improved, did not affect the follow-up treatment. There was statistical difference between the two groups of patients, P <0.05. Conclusion: The use of aluminum magnesium carbonate in combination with omeprazole in the treatment of active gastric ulcer has the advantages of strong safety, low risk and good clinical effect, which deserves further promotion.